POLYCYTHEMIA VERA (PV)

Clinical trials for POLYCYTHEMIA VERA (PV) explained in plain language.

Never miss a new study

Get alerted when new POLYCYTHEMIA VERA (PV) trials appear

Sign up with your email to follow new studies for POLYCYTHEMIA VERA (PV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 2 Not yet finished but already full! 2 Completed 1

New hope for polycythemia vera patients who Can't use standard drugs

Disease control Completed

This Phase 2 study tested a drug called P1101 (ropeginterferon alfa-2b) in 29 Japanese adults with polycythemia vera (PV), a blood disorder that causes too many red blood cells. The participants were people for whom standard treatments are hard to use, such as younger patients or…

Matched conditions: POLYCYTHEMIA VERA (PV)

Phase: PHASE2 • Sponsor: PharmaEssentia Japan K.K. • Aim: Disease control

Last updated Jun 26, 2026 17:14 UTC

POLYCYTHEMIA VERA (PV)

Get alerted when new POLYCYTHEMIA VERA (PV) trials appear

New hope for polycythemia vera patients who Can't use standard drugs